You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | -41,453.3% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -5.9 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 2,868.0 |
| Price / Book value | -17.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | -96.1% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 11.3% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 0.02 | -20.08 | €-0.65 | -0.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -13.25 | €-0.36 | -8.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -16.93 | €-0.37 | -7.9 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -21.18 | €-0.42 | -7.6 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | n/a | -28.73 | €-0.52 | -6.5 | 0.0 | n/a | n/a | 0.0% |
| Faron Pharmaceuticals names James O'Brien as CFO Sharecast News | 29 Mar |
|---|---|
| Faron Pharmaceuticals gets positive feedback from FDA meeting Sharecast News | 22 Mar |
| Board Member to Assume Transactional Advisor Role | 05-Jun-23 14:22 |
|---|---|
| BEXMAB study update | 17-Apr-23 14:52 |
| Appointment of Chief Financial Officer | 29-Mar-23 14:35 |
| Board Change | 24-Mar-23 22:26 |
| Results of AGM | 24-Mar-23 22:20 |